Rare variant analysis of 4,241 pulmonary arterial hypertension cases from an international consortium implicate<i>FBLN2</i>,<i>PDGFD</i>and rare<i>de novo</i>variants in PAH
bioRxiv (Cold Spring Harbor Laboratory)